(BRNL) Brunel International - Ratings and Ratios
Recruitment,Consultancy,ProjectManagement,WorkforceSolutions,GlobalMobility
Description: BRNL Brunel International
Brunel International NV is a global provider of human resource and employment services, operating in multiple regions including Europe, Australasia, the Middle East, India, Asia, and the Americas. The company offers a range of services including project management, recruitment, consultancy, and global mobility solutions to various industries such as life sciences, renewable energy, and infrastructure.
The companys services can be categorized into three main areas: project and consulting solutions, workforce solutions, and global mobility solutions. This diversified service portfolio allows Brunel to cater to the complex needs of its clients across different sectors and geographies. Key performance indicators (KPIs) that could be relevant for evaluating Brunels performance include revenue growth, gross margin, and client acquisition rates.
From a financial perspective, Brunel International NV has a market capitalization of approximately 449.47 million EUR, with a price-to-earnings ratio of 15.14 and a forward P/E of 14.60. The companys return on equity (RoE) stands at 18.24%, indicating a relatively strong profitability. Other relevant KPIs could include revenue per employee, employee retention rates, and the ratio of contract to permanent placements.
To further analyze Brunels stock, one could examine its technical indicators, such as the moving averages and average true range. While the stocks current price is 9.16, it has shown a relatively stable trend with its 20-day, 50-day, and 200-day moving averages at 9.10, 8.94, and 8.75, respectively. The ATR of 0.18 indicates a moderate level of price volatility.
BRNL Stock Overview
| Market Cap in USD | 496m |
| Sub-Industry | Human Resource & Employment Services |
| IPO / Inception |
BRNL Stock Ratings
| Growth Rating | 40.2% |
| Fundamental | 73.3% |
| Dividend Rating | 80.7% |
| Return 12m vs S&P 500 | -16.1% |
| Analyst Rating | - |
BRNL Dividends
| Dividend Yield 12m | 6.34% |
| Yield on Cost 5y | 10.68% |
| Annual Growth 5y | 16.36% |
| Payout Consistency | 77.2% |
| Payout Ratio | 3.1% |
BRNL Growth Ratios
| Growth Correlation 3m | -51.7% |
| Growth Correlation 12m | 53.8% |
| Growth Correlation 5y | 34.7% |
| CAGR 5y | 10.76% |
| CAGR/Max DD 5y | 0.31 |
| Sharpe Ratio 12m | -0.15 |
| Alpha | -17.82 |
| Beta | 0.930 |
| Volatility | 26.45% |
| Current Volume | 68.9k |
| Average Volume 20d | 81.2k |
| Stop Loss | 8.3 (-4%) |
| Signal | -2.21 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (54.8m TTM) > 0 and > 6% of Revenue (6% = 137.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 5.63pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 12.09% (prev 18.27%; Δ -6.19pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 74.6m > Net Income 54.8m (YES >=105%, WARN >=100%) |
| Net Debt (114.8m) to EBITDA (124.3m) ratio: 0.92 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (50.4m) change vs 12m ago -0.27% (target <= -2.0% for YES) |
| Gross Margin 31.16% (prev 38.58%; Δ -7.42pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 404.4% (prev 243.0%; Δ 161.4pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 11.11 (EBITDA TTM 124.3m / Interest Expense TTM 8.24m) >= 6 (WARN >= 3) |
Altman Z'' 4.49
| (A) 0.48 = (Total Current Assets 442.0m - Total Current Liabilities 165.2m) / Total Assets 582.0m |
| (B) 0.05 = Retained Earnings (Balance) 29.8m / Total Assets 582.0m |
| (C) 0.16 = EBIT TTM 91.5m / Avg Total Assets 566.3m |
| (D) 0.11 = Book Value of Equity 29.8m / Total Liabilities 264.6m |
| Total Rating: 4.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.27
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 6.30% = 3.15 |
| 3. FCF Margin 1.49% = 0.37 |
| 4. Debt/Equity 0.72 = 2.25 |
| 5. Debt/Ebitda 1.82 = 0.35 |
| 6. ROIC - WACC 8.00% = 10.00 |
| 7. RoE 18.24% = 1.52 |
| 8. Rev. Trend 32.36% = 1.62 |
| 9. Rev. CAGR 20.43% = 2.50 |
| 10. EPS Trend -39.30% = -0.98 |
| 11. EPS CAGR 0.0% = 0.0 |
What is the price of BRNL shares?
Over the past week, the price has changed by +3.10%, over one month by -6.79%, over three months by -3.67% and over the past year by -1.30%.
Is Brunel International a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BRNL is around 8.41 EUR . This means that BRNL is currently overvalued and has a potential downside of -2.77%.
Is BRNL a buy, sell or hold?
What are the forecasts/targets for the BRNL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.8 | 12.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.2 | 6.6% |
BRNL Fundamental Data Overview
Market Cap EUR = 425.8m (425.8m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 112.0m EUR (Cash only, last quarter)
P/E Trailing = 28.2
P/E Forward = 14.8368
P/S = 0.331
P/B = 1.5779
P/EG = 1.99
Beta = 0.699
Revenue TTM = 2.29b EUR
EBIT TTM = 91.5m EUR
EBITDA TTM = 124.3m EUR
Long Term Debt = 61.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 165.2m EUR (from totalCurrentLiabilities, last quarter)
Debt = 226.8m EUR (Calculated: Short Term 165.2m + Long Term 61.6m)
Net Debt = 114.8m EUR (calculated as Total Debt 226.8m - CCE 112.0m)
Enterprise Value = 540.6m EUR (425.8m + Debt 226.8m - CCE 112.0m)
Interest Coverage Ratio = 11.11 (Ebit TTM 91.5m / Interest Expense TTM 8.24m)
FCF Yield = 6.30% (FCF TTM 34.0m / Enterprise Value 540.6m)
FCF Margin = 1.49% (FCF TTM 34.0m / Revenue TTM 2.29b)
Net Margin = 2.39% (Net Income TTM 54.8m / Revenue TTM 2.29b)
Gross Margin = 31.16% ((Revenue TTM 2.29b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Tobins Q-Ratio = 18.11 (Enterprise Value 540.6m / Book Value Of Equity 29.8m)
Interest Expense / Debt = 1.84% (Interest Expense 4.18m / Debt 226.8m)
Taxrate = 38.24% (from quarterly Income Tax Expense: 9.69m / 25.3m)
NOPAT = 56.5m (EBIT 91.5m * (1 - 38.24%))
Current Ratio = 2.68 (Total Current Assets 442.0m / Total Current Liabilities 165.2m)
Debt / Equity = 0.72 (Debt 226.8m / last Quarter total Stockholder Equity 315.1m)
Debt / EBITDA = 1.82 (Net Debt 114.8m / EBITDA 124.3m)
Debt / FCF = 6.66 (Debt 226.8m / FCF TTM 34.0m)
Total Stockholder Equity = 300.5m (last 4 quarters mean)
RoA = 9.42% (Net Income 54.8m, Total Assets 582.0m )
RoE = 18.24% (Net Income TTM 54.8m / Total Stockholder Equity 300.5m)
RoCE = 25.28% (Ebit 91.5m / (Equity 300.5m + L.T.Debt 61.6m))
RoIC = 14.55% (NOPAT 56.5m / Invested Capital 388.4m)
WACC = 6.56% (E(425.8m)/V(652.6m) * Re(9.44%)) + (D(226.8m)/V(652.6m) * Rd(1.84%) * (1-Tc(0.38)))
Shares Correlation 5-Years: -86.60 | Cagr: -0.09%
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 77.04% ; FCFE base≈20.9m ; Y1≈25.8m ; Y5≈44.0m
Fair Price DCF = 11.57 (DCF Value 582.2m / Shares Outstanding 50.3m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 32.36 | Revenue CAGR: 20.43%
Rev Growth-of-Growth: 20.46
EPS Correlation: -39.30 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 342.3